KRYS
Price
$137.40
Change
-$1.48 (-1.07%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
4.01B
42 days until earnings call
ORMP
Price
$2.23
Change
+$0.07 (+3.26%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
87.83M
44 days until earnings call
Interact to see
Advertisement

KRYS vs ORMP

Header iconKRYS vs ORMP Comparison
Open Charts KRYS vs ORMPBanner chart's image
Krystal Biotech
Price$137.40
Change-$1.48 (-1.07%)
Volume$6.02K
Capitalization4.01B
Oramed Pharmaceuticals
Price$2.23
Change+$0.07 (+3.26%)
Volume$5.07K
Capitalization87.83M
KRYS vs ORMP Comparison Chart in %
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. ORMP commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Hold and ORMP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (KRYS: $138.88 vs. ORMP: $2.15)
Brand notoriety: KRYS and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 112% vs. ORMP: 86%
Market capitalization -- KRYS: $4.01B vs. ORMP: $87.83M
KRYS [@Biotechnology] is valued at $4.01B. ORMP’s [@Biotechnology] market capitalization is $87.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 1 bullish TA indicator(s).

  • KRYS’s TA Score: 4 bullish, 4 bearish.
  • ORMP’s TA Score: 1 bullish, 8 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than ORMP.

Price Growth

KRYS (@Biotechnology) experienced а +4.85% price change this week, while ORMP (@Biotechnology) price change was +0.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

KRYS is expected to report earnings on Aug 11, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.01B) has a higher market cap than ORMP($87.8M). KRYS has higher P/E ratio than ORMP: KRYS (33.30) vs ORMP (20.91). ORMP (-11.157) and KRYS (-11.349) have similar YTD gains . KRYS has higher annual earnings (EBITDA): 140M vs. ORMP (-21.53M). KRYS has more cash in the bank: 617M vs. ORMP (131M). ORMP has less debt than KRYS: ORMP (301K) vs KRYS (9.66M). KRYS has higher revenues than ORMP: KRYS (333M) vs ORMP (2M).
KRYSORMPKRYS / ORMP
Capitalization4.01B87.8M4,571%
EBITDA140M-21.53M-650%
Gain YTD-11.349-11.157102%
P/E Ratio33.3020.91159%
Revenue333M2M16,650%
Total Cash617M131M471%
Total Debt9.66M301K3,210%
FUNDAMENTALS RATINGS
KRYS vs ORMP: Fundamental Ratings
KRYS
ORMP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
41100
SMR RATING
1..100
5793
PRICE GROWTH RATING
1..100
6276
P/E GROWTH RATING
1..100
9851
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (59) in the Pharmaceuticals Other industry is in the same range as KRYS (71) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (41) in the Pharmaceuticals Major industry is somewhat better than the same rating for ORMP (100) in the Pharmaceuticals Other industry. This means that KRYS’s stock grew somewhat faster than ORMP’s over the last 12 months.

KRYS's SMR Rating (57) in the Pharmaceuticals Major industry is somewhat better than the same rating for ORMP (93) in the Pharmaceuticals Other industry. This means that KRYS’s stock grew somewhat faster than ORMP’s over the last 12 months.

KRYS's Price Growth Rating (62) in the Pharmaceuticals Major industry is in the same range as ORMP (76) in the Pharmaceuticals Other industry. This means that KRYS’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (51) in the Pharmaceuticals Other industry is somewhat better than the same rating for KRYS (98) in the Pharmaceuticals Major industry. This means that ORMP’s stock grew somewhat faster than KRYS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSORMP
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
72%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 14 days ago
76%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATLCY14.250.50
+3.64%
Atlas Copco AB
DNTUY22.440.38
+1.72%
Dentsu Group Inc.
CRHKY6.33-0.06
-0.94%
China Resources Beer Holdings Company Limited
HLGN1.50-0.05
-3.23%
Heliogen, Inc.
QNCCF1.20-0.16
-11.50%
Quantum eMotion Corp.

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-0.92%
BTAI - ORMP
44%
Loosely correlated
-12.81%
INO - ORMP
44%
Loosely correlated
-6.22%
MBIO - ORMP
44%
Loosely correlated
-0.97%
VERV - ORMP
44%
Loosely correlated
+0.40%
ZNTL - ORMP
43%
Loosely correlated
-6.35%
More